Cytomx Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 23.09, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Cytomx Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 16 days, from 9 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 407 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 1752 to 2399.

What is Receivable Turnover Ratio?
What is Cytomx Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CTMX Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-66.97 %	-35.13 %	-51.4 %	-32.65 %	-85.16 %
Y / Y Revenue Change	-79.85 %	-98.26 %	-82.16 %	-25.71 %	22.8 %
Receivable Turnover Ratio (TTM)	23.09	40.82	53.12	54.9	52.76
CTMX's Total Ranking	# 2399	# 1752	# 246	# 704	# 233
Accounts Receivable average collection period days	16	9	7	7	7
Seq. Receivable Change	-67.91 %	23.57 %	-12.84 %	-4.45 %	-36.96 %
Seq. Revenue Change	1447.21 %	-88.88 %	-68.04 %	-63.36 %	33.66 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 136
Healthcare Sector	# 408
Overall Market	# 2399

Receivable Turnover Ratio Statistics
High	Average	Low
1.14	0.33	0.1
(Mar 31 2025)		(Dec 31 2021)

CTMX Company Profile • Back to CTMX Efficiency Comparisons • Compare CTMX Receivables Turnover Ratio to its Competitors

Financial Statements
Cytomx Therapeutics Inc 's Accounts Receivable	$ 1 Millions	Visit CTMX's Balance sheet
Cytomx Therapeutics Inc 's Sales TTM	$ 36 Millions	Visit CTMX's Income Statement
Sources of CTMX's Revenues		Visit CTMX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CTMX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CTMX's Growth Rates	CTMX's Roa	CTMX's Inventory Turnover Ratio	CTMX's Dividend Comparisons
CTMX's Profitability Ratios	CTMX's Roi	CTMX's Asset Turnover Ratio	CTMX's Dividend Growth
CTMX's Valuation Ratios	CTMX's Roe	CTMX's Financial Strength Ratios	CTMX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Prime Medicine Inc	134.47	$ 4.034 Millions	$ 0.030 Millions
Earth Science Tech Inc	127.94	$ 33.712 Millions	$ 0.263 Millions
Lenz Therapeutics Inc	124.93	$ 20.989 Millions	$ 0.168 Millions
Agape Atp Corporation	123.42	$ 1.509 Millions	$ 0.012 Millions
Assembly Biosciences Inc	121.69	$ 71.097 Millions	$ 0.584 Millions
Harvard Apparatus Regenerative Technology Inc	88.50	$ 0.885 Millions	$ 0.010 Millions
Zeo Scientifix Inc	74.53	$ 6.987 Millions	$ 0.094 Millions
Airsculpt Technologies Inc	69.52	$ 151.836 Millions	$ 2.184 Millions
Sbc Medical Group Holdings Incorporated	64.95	$ 167.536 Millions	$ 2.579 Millions
Arrowhead Pharmaceuticals Inc	63.74	$ 622.009 Millions	$ 9.758 Millions
Hims and Hers Health Inc	63.35	$ 2,369.476 Millions	$ 37.405 Millions
Spero Therapeutics Inc	59.36	$ 61.186 Millions	$ 1.031 Millions
Humacyte Inc	58.59	$ 34.376 Millions	$ 0.587 Millions
Aim Immunotech Inc	53.71	$ 0.094 Millions	$ 0.002 Millions
Brookdale Senior Living Inc	49.21	$ 3,145.058 Millions	$ 63.914 Millions
Fortrea Holdings Inc	44.31	$ 2,708.600 Millions	$ 61.125 Millions
National Vision Holdings Inc	41.80	$ 2,021.044 Millions	$ 48.351 Millions
Metagenomi Therapeutics Inc	41.78	$ 22.331 Millions	$ 0.535 Millions
Mangoceuticals Inc	41.34	$ 0.415 Millions	$ 0.010 Millions
Nature s Sunshine Products inc	39.69	$ 489.104 Millions	$ 12.324 Millions
Lifevantage Corp	38.34	$ 193.618 Millions	$ 5.050 Millions
Longduoduo Co Ltd	35.04	$ 2.132 Millions	$ 0.061 Millions
Innovative Eyewear Inc	33.59	$ 2.981 Millions	$ 0.089 Millions
Electrocore Inc	32.90	$ 34.458 Millions	$ 1.047 Millions
U S Physical Therapy Inc	30.94	$ 795.488 Millions	$ 25.708 Millions
Innovage Holding Corp	30.93	$ 949.172 Millions	$ 30.688 Millions
Invo Fertility Inc	29.40	$ 7.219 Millions	$ 0.246 Millions
Lineage Cell Therapeutics Inc	28.42	$ 14.779 Millions	$ 0.520 Millions
Meiragtx Holdings Plc	28.01	$ 79.758 Millions	$ 2.848 Millions
Cv Sciences Inc	27.37	$ 11.925 Millions	$ 0.436 Millions

Date modified: 2026-08-29T17:33:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.